EMA relocation updates

EMA

23 January 2019 - The EMA will physically relocate to the Netherlands in early March 2019. 

The Dutch authorities have already officially handed over the temporary building, the Spark building in Amsterdam Sloterdijk, to EMA’s Executive Director Guido Rasi on 9 January 2019 and EMA is now preparing for its physical move. Whilst relocating, the Agency has to ensure the continuation of its main activities throughout the move and has implemented phase 4 of its business continuity plan accordingly. 

The focus will be on the authorisation, maintenance and supervision of medicines, ongoing Brexit preparedness/implementation activities and preparing for the implementation of the new veterinary legislation (highest priority – category 1 activities).

Read EMA press release

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , Europe , Regulation , Brexit